Cargando…
Initial Experience of Intentional Internal High-Dose Policy Volumetric Modulated Arc Therapy of Neck Lymph Node Metastases ≥ 2 cm in Patients With Head and Neck Squamous Cell Carcinoma
BACKGROUND AND PURPOSE: Most locoregional recurrences after definitive radiotherapy for head and neck squamous cell carcinoma (HNSCC) develop “in-field.” Dose escalation while sparing organs at risk can be a good solution for improving local control without increasing adverse effects. This study inv...
Autores principales: | Kashihara, Tairo, Nakamura, Satoshi, Murakami, Naoya, Ito, Kimiteru, Matsumoto, Yoshifumi, Kobayashi, Kenya, Omura, Go, Mori, Taisuke, Honma, Yoshitaka, Kubo, Yuko, Okamoto, Hiroyuki, Takahashi, Kana, Inaba, Koji, Okuma, Kae, Igaki, Hiroshi, Nakayama, Yuko, Kato, Ken, Matsumoto, Fumihiko, Yoshimoto, Seiichi, Itami, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112241/ https://www.ncbi.nlm.nih.gov/pubmed/33987086 http://dx.doi.org/10.3389/fonc.2021.651409 |
Ejemplares similares
-
Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy
por: Murakami, Naoya, et al.
Publicado: (2019) -
Non-Robustness of Ang’s Risk Classification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma in Japanese Patients
por: Itami, Jun, et al.
Publicado: (2022) -
Per-oral interstitial brachytherapy catheter insertion for boost in case of recurrent tonsillar carcinoma: dosimetry and clinical outcome
por: Murakami, Naoya, et al.
Publicado: (2020) -
Prognostic impact of immunohistopathologic features in definitive radiation therapy for nasopharyngeal cancer patients
por: Murakami, Naoya, et al.
Publicado: (2019) -
Image-guided interstitial brachytherapy boost for keratinizing squamous cell carcinoma of inferior wall of the nasopharynx
por: Murakami, Naoya, et al.
Publicado: (2020)